BungumL, FranssohnF, BungumM,Humaidan P,GivercmanA.The circadian variation in anti-Müllerian hormone in patients with polycystic ovary syndrome differs significantly from normally ovulating

variation in anti-Müllerian hormone in patients with polycystic ovary syndrome differs significantly from normally ovulating women. PLoS One 2013;9:e68223. Dolleman M, Faddy MJ, van Disseldorp J, van der Schouw TY, Messow CM, Leader B, Peeters PH, McConnachie A, Nelson SM, Broekmans FJ. The relationship between anti-Müllerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies. J Clin Enodocrinol Metab 2013;98:1946–1953. Fitzgerald C, Rustamov O, Pemberton P, Smith A, Yates A, Krishnan M, Russel R, Nardo L, Roberts S. AMH Assays: a review of the literature on assay method comparability. Hum Reprod 2013;28(Suppl 1): 0–184. Hadlow N, Longhurst K, McClements A, Natalwala J, Brown SJ, Matson PL. Variation in anti-Müllerian hormone concentration during the menstrual cycle may change the clinical classification of the ovarian response. Fertil Steril 2013;99:1791–1797. Han X, McShane M, Sahertian R, White C, Ledger W. Pre-mixing samples with assay buffer is an essential pre-requisite for reproducible anti-Müllerian hormone (AMH) measurement using the Beckman Coulter Gen II assay (Gen II). Hum Reprod 2013;28(Suppl 1):0–185. Khader A, Lloyd SM, McConnaichie A, Fleming R, Grisendi V, La Marca A, Nelson SM. External validation of anti-Müllerian hormone based prediction of live birth in assisted conception. J Ovarian Res 2013;6:3. La Marca A, Sighinolfi G, Siulini S, Traglia M, Argento C, Sala C, Masciullo C, Volpe A, Toniolo D. Normal serum concentrations of anti-Müllerian hormone in women with regular menstrual cycles. Reprod BioMed Online 2010;21:463–469. La Marca A, Spada E, Grisendi V, Argento C, Papale E, Milani S, Volpe A. Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history. Eur J Obstet Gynecol Reprod Biol 2012;163:180–184. Li HW, Ng EH, Wong BP, Anderson RA, Ho PC, Yeung WS. Correlation between three assay systems for anti-Müllerian hormone (AMH) determination. J Assist Reprod Genet 2012;29:1443–1446. Li HW, Lee VC, Lau EY, Yeung WS, Ho PC, Ng EH. Role of baseline antral follicle count and anti-Müllerian hormone in prediction of cumulative live birth in the first in vitro fertilization cycle: a retrospective cohort analysis. PLoS One 2013;8:e61095. Loh JS, Maheshwari A. Anti-Müllerian hormone is it a crystal ball for predicting ovarian aging? Hum Reprod 2011;26:2925–2932. Nelson SM. Anti-Müllerian hormone: is the writing on the wall for antral follicle count [letter]? Fertil Steril 2013;99:1563–1564. Nelson SM, La Marca A. The journey from the old to the new AMH assay: how to avoid getting lost in the values. Reprod Biomed Online 2011;23:411–420. Rustamov O, Smith A, Roberts SA, Yates AP, Firzgearld C, Krishnan M, Nardo LG, Pemberon PW. Anti-Müllerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability. Hum Reprod 2012;27:3085–3091. Seifer DB, Baker VL, Leader B. Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United states. Fertil Steril 2011;95:747–750. Syme NR, Al-Sadie R, Sturgeon C. Is performance for anti-Müllerian hormone improving? Evidence from UK NEQAS. Ann Clin Biochem 2013;50(Suppl 1):37–38. Tremellen K, Kolo M. Serum anti-Müllerian hormone is a useful measure of quantitative ovarian reserve but does not predict the chances of live-birth pregnancy. Aust N Z J Obstet Gynecol 2010;50:568–572. Usta T, Oral I. Is the measurement of anti-Müllerian hormone essential? Curr Opin Obstet Gynecol 2012;24:151–157. WallaceAM, Faye SA, Fleming R,Nelson SM. Amulticentre evaluation of the new Beckman Coulter anti-Müllerian hormone immunoassay (AMH Gen II). Ann Clin Biochem 2011;48:370–373.